Statin use and reduced cancer-related mortality

Sune F Nielsen; Børge G Nordestgaard; Stig E Bojesen

doi:10.1056/NEJMoa1201735

Statin use and reduced cancer-related mortality

Sune F Nielsen, Børge G Nordestgaard, Stig E Bojesen

822 Citationer (Scopus)

Abstract

A reduction in the availability of cholesterol may limit the cellular proliferation required for cancer growth and metastasis. We tested the hypothesis that statin use begun before a cancer diagnosis is associated with reduced cancer-related mortality.

Originalsprog	Engelsk
Tidsskrift	New England Journal of Medicine
Vol/bind	367
Udgave nummer	19
Sider (fra-til)	1792-802
Antal sider	11
ISSN	0028-4793
DOI	https://doi.org/10.1056/NEJMoa1201735
Status	Udgivet - 2012

Adgang til dokumentet

10.1056/NEJMoa1201735

Citationsformater

@article{c480a2a1b8114262b1f441db2049f1d9,

title = "Statin use and reduced cancer-related mortality",

abstract = "A reduction in the availability of cholesterol may limit the cellular proliferation required for cancer growth and metastasis. We tested the hypothesis that statin use begun before a cancer diagnosis is associated with reduced cancer-related mortality.",

author = "Nielsen, {Sune F} and Nordestgaard, {B{\o}rge G} and Bojesen, {Stig E}",

year = "2012",

doi = "10.1056/NEJMoa1201735",

language = "English",

volume = "367",

pages = "1792--802",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "19",

}

TY - JOUR

T1 - Statin use and reduced cancer-related mortality

AU - Nielsen, Sune F

AU - Nordestgaard, Børge G

AU - Bojesen, Stig E

PY - 2012

Y1 - 2012

N2 - A reduction in the availability of cholesterol may limit the cellular proliferation required for cancer growth and metastasis. We tested the hypothesis that statin use begun before a cancer diagnosis is associated with reduced cancer-related mortality.

AB - A reduction in the availability of cholesterol may limit the cellular proliferation required for cancer growth and metastasis. We tested the hypothesis that statin use begun before a cancer diagnosis is associated with reduced cancer-related mortality.

U2 - 10.1056/NEJMoa1201735

DO - 10.1056/NEJMoa1201735

M3 - Journal article

C2 - 23134381

SN - 0028-4793

VL - 367

SP - 1792

EP - 1802

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 19

ER -

Statin use and reduced cancer-related mortality

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater